3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
20
Phase 2
17
Phase 3
7
Phase 1/2
4
Phase NA
2
Phase 4
2
Phase EARLY_PHASE1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Gastrointestinal Stromal Tumors
10
Bone Neoplasms
9
Sarcoma
8
Neoplasms
3
Multiple Myeloma
3
Sarcoma, Kaposi
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Osteosarcoma
2
Neoplasm Metastasis
2
Lymphoma
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Anemia
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma, Alveolar
1
Renal Insufficiency
1
Recurrence
1
Rectal Neoplasms
1
Psoriasis
1
Prostatic Neoplasms
1
Progressive Gastrointestinal Stromal Tumor
1
Piebaldism
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Interventions
Ritonavir
1
Nevirapine
1
Lopinavir
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Emtricitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Acquired Immunodeficiency Syndrome
×
Sarcoma
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled
NCT00380770
2010-07-21
KAART
University of KwaZulu
Phase 4
Completed
112 enrolled